论文部分内容阅读
瑞士Grindelwald消息:在此地召开的第二届国际当代传染病专题讨论会上,法国里昂Eduard Herriot医院的Christian Trepo说,最近发现和测定了与非甲非乙型肝炎(NANB)相关的肝脏酶类的增加,并认识到用γ球蛋白被动免疫可能使病人受益。 NANB约占北美和欧洲一些国家全部肝炎病例的20％。在日本,NANB占全部肝炎病例近一半。至于病因,研究人员在肝脏内分离出小球形颗粒,在某些方面,此种颗粒类似引起乙型
Grindelwald, Switzerland: Christian Trepo at the Eduard Herriot Hospital in Lyon, France, said at the second International Symposium on Contemporary Infectious Diseases here that the recent discovery and determination of liver enzymes associated with non-A, B, and B (NANB) Increase, and recognize that passive immunization with gamma globulin may benefit patients. NANB accounts for about 20% of all hepatitis cases in North America and some European countries. In Japan, NANB accounts for nearly half of all hepatitis cases. As for the etiology, the researchers isolated small spherical particles in the liver, which in some ways resembled type B